Cardiac Involvement in COVID-19

Guest: Patricia A. Pellikka, M.D. (@pattypellikka)

Host: Paul A. Friedman, M.D. (@drpaulfriedman)

Early reports from Wuhan, China, noted that patients with underlying cardiovascular disease had a higher risk of morbidity and mortality if they contracted the COVID-19 virus. More recently, data support that patients with evidence of cardiac disease during their COVID-19 episodes also have higher rates of morbidity and mortality during hospitalization for treatment of COVID-19.

Joining us today to discuss the cardiac involvement in patients with COVID-19 is Patricia A. Pellikka, M.D., vice chair of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota.

Specific topics discussed:

• Significance of cardiac involvement in patients with COVID-19
• Diagnosis of cardiac dysfunction in patients with COVID-19
• Myocarditis and other cardiac injury in patients with COVID-19
• Implications of MRI-identified myocarditis
• COVID-19 long-haulers and cardiac evaluation
• Artificial intelligence in electrocardiogram or echocardiogram

Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV.

No CME credit offered for this episode.

Podcast episode transcript here.